Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Epivir approved for European market

Aug. 23, 1996

Norvir approved by Canadian authorities

Aug. 23, 1996

Dainabot seeks Japanese approval of Norvir

Aug. 23, 1996

Roxane Laboratories has begun U.S. nevirapine distribution

Aug. 23, 1996

Vistide marketing collaboration established

Aug. 23, 1996

WHO studies role of progesterone in HIV transmission

Aug. 16, 1996

HIV vaccine research at NIAID

Aug. 16, 1996

HIV integrase inhibitor effective, non-toxic in vitro

Aug. 16, 1996

Higher doses of GEM-91 administered in phase I/II trial

Aug. 16, 1996

Preclinical development of GEM-92 underway at Hybridon

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...